查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1762497

高雪氏症治疗的全球市场:市场规模·占有率·趋势，产业分析 (类别·各治疗法·各流通管道·各地区)，未来预测 (2025年～2034年)

Gaucher Disease Treatment Market Size, Share, Trends, & Industry Analysis Report: By Type (Type 1, Type 3, Type 2), By Therapy, By Distribution Channel, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，全球戈谢氏症治疗市场规模将达到 21 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

戈谢氏症是最常见的脂质体贮积症之一，由葡萄糖脑苷脂酶（一种分解脂肪化合物，尤其是葡萄糖脑苷脂的酵素）缺乏所引起。这种酵素缺乏会促使葡萄糖脑苷脂积聚，进而促使脾臟、肝臟和骨髓中形成戈谢细胞。此疾病的主要症状包括脾臟和肝臟肿大、疲劳、贫血、骨骼不适和骨折以及出血等。

随着人们对戈谢氏症（一种罕见遗传性疾病）认识的提高，其诊断和治疗也正在不断进步。认识的提高使更多人能够获得早期诊断，从而改善了疾病管理。宣传活动、强化筛检以及加强对医务人员的培训都促进了这一进步。此外，在高发生率地区扩大并优先开展新生儿筛检项目，显着提高了早期发现和及时治疗的效果。

美国食品药物管理局 (FDA) 批准的药品数量不断增加，也推动了戈谢氏症治疗市场的发展，鼓励主要市场参与者在药物开发中采用创新策略。此外，生物製药公司与研究机构之间的合作预计将在未来几年推动市场成长。

戈谢氏症治疗市场的竞争凸显了领先公司不断寻求开发新颖、更有效的治疗方法。各公司正专注于探索治疗方法的进步和现有治疗方法的替代方案，以满足日益增长的改善患者预后的需求。

戈谢氏症治疗市场：分析概述

依治疗方法划分，酵素替代疗法占据市场主导地位，2024 年的收入占有率为 67.9%。

按类型划分，戈谢病最常见的类型 1 型，由于患者数量的增加，在 2024 年以 75% 的收入占有率领先市场。

由于人们对戈谢氏症的认识不断提高、医疗基础设施不断加强以及药物研发活动不断活跃，北美在 2024 年以 47.4% 的收入占有率占据全球市场主导地位。

预计亚太地区将在预测期内实现最快成长。该地区强劲的成长归功于医疗基础设施的改善以及政府为提高人们对罕见和危及生命的疾病的认识而采取的举措。

戈谢氏症治疗市场的主要参与者包括辉瑞公司、杨森製药公司、JCR製药公司、赛诺菲健赞、武田製药有限公司、强生服务公司、Shire Human Genetics Therapeutics, Inc. 和 Elad Therapeutics。

目录

第1章 简介

第2章 摘要整理

第3章 分析方法

第4章 全球高雪氏症治疗市场洞察

  • 市场概述
  • 高雪氏症治疗的市场动态
    • 促进因素和机会
      • 医疗成本上涨
      • 加强策略合作、收购与伙伴关係
    • 阻碍因素与课题
      • 初始製造成本上升
  • 大环境分析
  • 高雪氏症治疗市场趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球高雪氏症治疗市场:类别

  • 主要的分析结果
  • 简介
  • 第一型
  • 3型
  • 2型

第6章 全球高雪氏症治疗市场:各治疗法

  • 主要的分析结果
  • 简介
  • 酵素补充疗法(ERT)
  • 基材还原疗法(SRT)
  • 其他

第7章 全球高雪氏症治疗市场:各流通管道

  • 主要的分析结果
  • 简介
  • 医院药局
  • 零售药局
  • 线上药局

第8章 全球高雪氏症治疗市场:各地区

  • 主要的分析结果
  • 简介
    • 高雪氏症治疗市场分析:各地区 (2020～2034年)
  • 北美
    • 北美:类别(2020～2034年)
    • 北美:各治疗法(2020～2034年)
    • 北美:各流通管道(2020～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:类别(2020～2034年)
    • 欧洲:各治疗法(2020～2034年)
    • 欧洲:各流通管道(2020～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:类别(2020～2034年)
    • 亚太地区:各治疗法(2020～2034年)
    • 亚太地区:各流通管道(2020～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:类别(2020～2034年)
    • 中东·非洲:各治疗法(2020～2034年)
    • 中东·非洲:各流通管道(2020～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:类别，2020-2034年
    • 南美:各治疗法(2020～2034年)
    • 南美:各流通管道(2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 事业扩大·企业收购的分析
    • 事业扩大
    • 企业收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • Amicus Therapeutics, Inc.
  • CANbridge Life Sciences Ltd.
  • Eli Lilly and Company
  • Johnson & Johnson, Inc.
  • Lingyi Biotechnology
  • Protalix Biotherapeutics Inc.
  • Sanofi
  • Spur Therapeutics
  • Takeda Pharmaceutical
Product Code: PM1514

The global Gaucher disease treatment market size is expected to reach USD 2.10 billion by 2034, according to a new study by Polaris Market Research. The report "Gaucher Disease Treatment Market Size, Share, Trends, Industry Analysis Report: By Therapy (Substrate Replacement Therapy, Enzyme Replacement Therapy, and Others), Type, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Gaucher disease is one of the most common liposomal storage disorders, caused by a deficiency of glucocerebrosidase, an enzyme responsible for breaking down fatty compounds, specifically glucocerebroside. This enzyme deficiency leads to the accumulation of glucocerebroside, resulting in the formation of Gaucher cells in the spleen, liver, and bone marrow. This condition is primarily characterized by symptoms such as an enlarged spleen or liver, fatigue, anemia, bone discomfort and fractures, and bleeding.

The diagnosis and treatment of Gaucher disease, a rare genetic disorder, are evolving due to increasing awareness of the condition. With greater awareness, more individuals are receiving earlier diagnoses, leading to improved disease management. Awareness campaigns, enhanced screening initiatives, and increased training for healthcare professionals support this progress. Additionally, the expansion and prioritization of newborn screening programs in regions with higher prevalence are significantly improving early identification and timely treatment.

The Gaucher disease treatment market is also driven by an increasing number of drug approvals from the US Food and Drug Administration (FDA), encouraging leading market players to adopt innovative strategies in drug development. Additionally, collaborations between biopharmaceutical and research institutions are expected to accelerate market growth in the coming years.

The competitive nature of the Gaucher disease treatment market highlights that leading players are constantly seeking to develop more novel and effective treatment alternatives. Companies are focused on advancing medical therapies and exploring alternatives to existing treatments, aiming to meet the growing demand for improved patient outcomes.

Key Highlights of Gaucher Disease Treatment Market Report

Based on therapy, the enzyme replacement therapy segment dominated the market with a 67.9% revenue share in 2024, driven by the high number of FDA-approved medications for the therapy.

By type, the Type 1 segment led the market with a 75% revenue share in 2024 due to a rise in patient occurrence, as this is the most commonly occurring type of Gaucher's disease.

North America dominated the global market with a 47.4% revenue share in 2024, driven by greater awareness of Gaucher disease, enhanced healthcare infrastructure, and increasing drug discovery and research activities.

Asia Pacific is expected to register the fastest growth during the forecast period. The region's robust growth is attributed to improved healthcare infrastructure and government efforts to raise awareness about rare and life-threatening diseases.

Key players in the Gaucher disease treatment market include Pfizer Inc.; Janssen Pharmaceuticals; JCR Pharmaceuticals Co Ltd.; Sanofi Genzyme; Takeda Pharmaceuticals; Johnson & Johnson Services, Inc.; Shire Human Genetics Therapies, Inc.; Erad Therapeutic Inc.; and ERAD Therapeutics.

Polaris Market Research has segmented the Gaucher disease treatment market report on the basis of therapy, type, and region:

Gaucher Disease Treatment Market Segmentation

By Therapy Outlook (Revenue - USD Billion, 2020-2034)

Substrate Replacement Therapy

Enzyme Replacement Therapy

Others

By Type Outlook (Revenue - USD Billion, 2020-2034)

Type 1

Type 2

Type 3

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of the Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Gaucher Disease Treatment Market Report Scope

Report Attributes

Details

Market Size Value in 2024

USD 1.64 billion

Market Size Value in 2025

USD 1.67 billion

Revenue Forecast by 2034

USD 2.10 billion

CAGR

  • 2.54% from 2025 to 2034

Base Year

2024

Historical Data

2020-2023

Forecast Period

2025-2034

Quantitative Units

Revenue in USD billion and CAGR from 2025 to 2034

Report Coverage

Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends

Segments Covered

By Therapy

By Type

Regional Scope

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Competitive Landscape

Gaucher Disease Treatment Industry Trends Analysis (2024)

Company profiles/industry participants profiling includes company overview, financial information, product/service benchmarking, and recent developments

Report Format

PDF + Excel

Customization

Report customization as per your requirements with respect to countries, regions, and segmentation.

For Specific Research Requirements

Request for Customized Report

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Gaucher Disease Treatment Market Insights

  • 4.1. Gaucher Disease Treatment Market - Market Snapshot
  • 4.2. Gaucher Disease Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Healthcare Spending
      • 4.2.1.2. Increasing Strategic Collaboration, Acquisition, and Partnership
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Initial Cost of Manufacturing
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Gaucher Disease Treatment Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Gaucher Disease Treatment Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Type 1
    • 5.3.1. Global Gaucher Disease Treatment Market, by Type 1, by Region, 2020-2034 (USD Billion)
  • 5.4. Type 3
    • 5.4.1. Global Gaucher Disease Treatment Market, by Type 3, by Region, 2020-2034 (USD Billion)
  • 5.5. Type 2
    • 5.5.1. Global Gaucher Disease Treatment Market, by Type 2, by Region, 2020-2034 (USD Billion)

6. Global Gaucher Disease Treatment Market, by Therapy

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • 6.3. Enzyme Replacement Therapy (ERT)
    • 6.3.1. Global Gaucher Disease Treatment Market, by Enzyme Replacement Therapy (ERT), by Region, 2020-2034 (USD Billion)
  • 6.4. Substrate Reduction Therapy (SRT)
    • 6.4.1. Global Gaucher Disease Treatment Market, by Substrate Reduction Therapy (SRT), by Region, 2020-2034 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Gaucher Disease Treatment Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Gaucher Disease Treatment Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.3. Hospital Pharmacies
    • 7.3.1. Global Gaucher Disease Treatment Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Gaucher Disease Treatment Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Gaucher Disease Treatment Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)

8. Global Gaucher Disease Treatment Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Gaucher Disease Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Gaucher Disease Treatment Market - North America
    • 8.3.1. North America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
    • 8.3.3. North America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.4. Gaucher Disease Treatment Market - U.S.
      • 8.3.4.1. U.S.: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.5. Gaucher Disease Treatment Market - Canada
      • 8.3.5.1. Canada: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.4. Gaucher Disease Treatment Market - Europe
    • 8.4.1. Europe: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.4. Gaucher Disease Treatment Market - UK
      • 8.4.4.1. UK: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.5. Gaucher Disease Treatment Market - France
      • 8.4.5.1. France: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.6. Gaucher Disease Treatment Market - Germany
      • 8.4.6.1. Germany: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.7. Gaucher Disease Treatment Market - Italy
      • 8.4.7.1. Italy: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.8. Gaucher Disease Treatment Market - Spain
      • 8.4.8.1. Spain: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.9. Gaucher Disease Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.10. Gaucher Disease Treatment Market - Russia
      • 8.4.10.1. Russia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.11. Gaucher Disease Treatment Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.5. Gaucher Disease Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.4. Gaucher Disease Treatment Market - China
      • 8.5.4.1. China: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.5. Gaucher Disease Treatment Market - India
      • 8.5.5.1. India: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.6. Gaucher Disease Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.7. Gaucher Disease Treatment Market - Japan
      • 8.5.7.1. Japan: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.8. Gaucher Disease Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.9. Gaucher Disease Treatment Market - South Korea
      • 8.5.9.1. South Korea: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.10. Gaucher Disease Treatment Market - Australia
      • 8.5.10.1. Australia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.11. Gaucher Disease Treatment Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.6. Gaucher Disease Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.4. Gaucher Disease Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.5. Gaucher Disease Treatment Market - UAE
      • 8.6.5.1. UAE: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.6. Gaucher Disease Treatment Market - Israel
      • 8.6.6.1. Israel: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.7. Gaucher Disease Treatment Market - South Africa
      • 8.6.7.1. South Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.8. Gaucher Disease Treatment Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.7. Gaucher Disease Treatment Market - Latin America
    • 8.7.1. Latin America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.4. Gaucher Disease Treatment Market - Mexico
      • 8.7.4.1. Mexico: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.5. Gaucher Disease Treatment Market - Brazil
      • 8.7.5.1. Brazil: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.6. Gaucher Disease Treatment Market - Argentina
      • 8.7.6.1. Argentina: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.7. Gaucher Disease Treatment Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Amicus Therapeutics, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. CANbridge Life Sciences Ltd.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Eli Lilly and Company
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Johnson & Johnson, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Lingyi Biotechnology
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Protalix Biotherapeutics Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Sanofi
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Spur Therapeutics
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Takeda Pharmaceutical
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development

List of Tables:

  • Table 1 Global Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 3 Global Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 4 North America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 5 North America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 6 North America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 7 U.S.: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 9 U.S.: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 10 Canada: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 12 Canada: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 13 Europe: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 15 Europe: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 16 UK: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 17 UK: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 18 UK: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 19 France: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 20 France: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 21 France: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 22 Germany: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 24 Germany: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 25 Italy: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 27 Italy: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 28 Spain: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 30 Spain: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 34 Russia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 36 Russia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 43 China: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 44 China: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 45 China: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 46 India: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 47 India: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 48 India: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 52 Japan: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 54 Japan: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 58 South Korea: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 60 South Korea: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 61 Australia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 63 Australia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 73 UAE: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 75 UAE: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 76 Israel: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 78 Israel: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 79 South Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 81 South Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 85 Latin America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 87 Latin America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 88 Mexico: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 90 Mexico: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 91 Brazil: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 93 Brazil: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 94 Argentina: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 96 Argentina: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Gaucher Disease Treatment Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Gaucher Disease Treatment Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Therapy
  • Figure 9. Global Gaucher Disease Treatment Market, by Therapy, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Gaucher Disease Treatment Market, by Distribution Channel, 2024 & 2034 (USD Billion)
  • Figure 12. Global Gaucher Disease Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
  • Figure 13. Strategic Analysis - Global Gaucher Disease Treatment Market